These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25967953)

  • 1. Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
    Pacholewicz J; Kuliczkowski W; Kaczmarski J; Zakliczyński M; Garbacz M; Zembala M; Serebruany V
    Cardiology; 2015; 131(3):172-6. PubMed ID: 25967953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
    Kamath S; Blann AD; Chin BS; Lip GY
    J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.
    Slaughter MS; Sobieski MA; Graham JD; Pappas PS; Tatooles AJ; Koenig SC
    Int J Artif Organs; 2011 Jun; 34(6):461-8. PubMed ID: 21725928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for anticoagulation of children on mechanical circulatory support.
    Copeland H; Nolan PE; Covington D; Gustafson M; Smith R; Copeland JG
    Artif Organs; 2011 Nov; 35(11):1018-23. PubMed ID: 22097979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism.
    Rose EA; Levin HR; Oz MC; Frazier OH; Macmanus Q; Burton NA; Lefrak EA
    Circulation; 1994 Nov; 90(5 Pt 2):II87-91. PubMed ID: 7955291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
    Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation.
    Kato TS; Colombo PC; Nahumi N; Kitada S; Takayama H; Naka Y; Di Tullio MR; Homma S; Mancini D; Jorde UP; Uriel N
    Echocardiography; 2014; 31(1):E5-9. PubMed ID: 24063315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation and aggregation profile in prolonged external ventricular support.
    Houël R; Mazoyer E; Boval B; Kirsch M; Vermès E; Drouet L; Loisance DY
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):197-202. PubMed ID: 15282455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
    Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
    JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimen.
    Ashbrook M; Walenga JM; Schwartz J; Heroux A; Jeske WP; Escalante V; Bakhos M
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):249-55. PubMed ID: 23162019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal anticoagulation in patients with a left ventricular assist device?
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.